These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 10321453)

  • 1. Anti-hyperglycemic activity of moxonidine: metabolic and molecular effects in obese spontaneously hypertensive rats.
    Friedman JE; Ishizuka T; Liu S; Farrell CJ; Koletsky RJ; Bedol D; Ernsberger P
    Blood Press Suppl; 1998; 3():32-9. PubMed ID: 10321453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of antihyperglycemic effects of moxonidine in the obese spontaneously hypertensive Koletsky rat (SHROB).
    Ernsberger P; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Friedman JE
    J Pharmacol Exp Ther; 1999 Jan; 288(1):139-47. PubMed ID: 9862764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of I(1)-imidazoline and alpha(2)-adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Aug; 306(2):646-57. PubMed ID: 12756274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology in the obese spontaneous hypertensive Koletsky rat: a model of syndrome X.
    Ernsberger P; Koletsky RJ; Friedman JE
    Ann N Y Acad Sci; 1999 Nov; 892():272-88. PubMed ID: 10842668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X.
    Velliquette RA; Friedman JE; Shao J; Zhang BB; Ernsberger P
    J Pharmacol Exp Ther; 2005 Jul; 314(1):422-30. PubMed ID: 15833894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting metabolic effects of antihypertensive agents.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1104-11. PubMed ID: 14557373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
    Ernsberger P; Koletsky RJ; Collins LA; Bedol D
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.
    Ernsberger P; Friedman JE; Koletsky RJ
    J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marked insulin resistance in obese spontaneously hypertensive rat adipocytes is ameliorated by in vivo but not in vitro treatment with moxonidine.
    Sun Z; Ernsberger P
    J Pharmacol Exp Ther; 2007 Feb; 320(2):845-52. PubMed ID: 17095615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced insulin receptor signaling in the obese spontaneously hypertensive Koletsky rat.
    Friedman JE; Ishizuka T; Liu S; Farrell CJ; Bedol D; Koletsky RJ; Kaung HL; Ernsberger P
    Am J Physiol; 1997 Nov; 273(5):E1014-23. PubMed ID: 9374689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of moxonidine in spontaneously hypertensive obese rats.
    Mukaddam-Daher S; Menaouar A; El-Ayoubi R; Gutkowska J; Jankowski M; Velliquette RA; Ernsberger P
    Ann N Y Acad Sci; 2003 Dec; 1009():244-50. PubMed ID: 15028594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats.
    Zhao M; Li Y; Wang J; Ebihara K; Rong X; Hosoda K; Tomita T; Nakao K
    Diabetes Obes Metab; 2011 Dec; 13(12):1123-9. PubMed ID: 21749604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study.
    Mikulášková B; Holubová M; Pražienková V; Zemenová J; Hrubá L; Haluzík M; Železná B; Kuneš J; Maletínská L
    Nutr Diabetes; 2018 Jan; 8(1):5. PubMed ID: 29339795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.
    Henriksen EJ; Jacob S; Fogt DL; Youngblood EB; Gödicke J
    Hypertension; 1997 Dec; 30(6):1560-5. PubMed ID: 9403583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-lowering actions of imidazoline antihypertensive agents in metabolic syndrome X.
    Velliquette RA; Kossover R; Previs SF; Ernsberger P
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):300-12. PubMed ID: 16416266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome.
    Bitto A; Altavilla D; Bonaiuto A; Polito F; Minutoli L; Di Stefano V; Giuliani D; Guarini S; Arcoraci V; Squadrito F
    J Endocrinol; 2009 Mar; 200(3):367-76. PubMed ID: 19066292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of I(1)-imidazoline receptors and alpha(2)-adrenergic receptors in the modulation of glucose and lipid metabolism in the SHROB model of metabolic syndrome X.
    Koletsky RJ; Velliquette RA; Ernsberger P
    Ann N Y Acad Sci; 2003 Dec; 1009():251-61. PubMed ID: 15028595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.